Vanguard Capital Management
IMNN icon

Vanguard Capital Management’s Imunon IMNN Stock Holding History

Vanguard Capital Management’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.6K Sell
46,967
-1,089
-2% -$2.69K ﹤0.01% 3893
2026
Q1 		$141K Buy
+48,056
New +$158K ﹤0.01% 3834

Other funds holding IMNN

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $349M AUM 33.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Vanguard Capital Management's IMNN Position: Q2 2026 in Review

Vanguard Capital Management reduced its Imunon (IMNN) stake by 2.3% in Q2 2026, selling an estimated $2.69K and leaving 46,967 shares worth $83.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3893.

Vanguard Capital Management first reported a position in IMNN in Q1 2026 and has held it in 2 quarters since. The position peaked at $141K in Q1 2026. 24 funds tracked by Wall St. Rank hold IMNN as of Q2 2026.

  • Vanguard Capital Management held 46,967 shares of Imunon worth $83.6K as of Q2 2026.
  • Vanguard Capital Management sold 1,089 Imunon shares in Q2 2026, an estimated $2.69K.
  • Imunon made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3893 holding.
  • Vanguard Capital Management first reported a position in Imunon in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Imunon position peaked at $141K in Q1 2026.
  • 24 funds tracked by Wall St. Rank held Imunon as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.